Covid lifeline as wonder-drug from UK firm 'crushes all 37 mutations of Omicron'

A COVID early treatment developed by British-American drugmaker GSK has proven effective against all new mutations of the Omicron variant, the company has claimed.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.